Comparing two ways of giving chemo into the belly for stomach cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests a new way of giving chemotherapy for stomach cancer that has spread to the lining of your belly (peritoneum). It compares two methods of giving chemo directly into the belly during a small surgery, to see which works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- Your stomach cancer has spread to the lining of your belly (peritoneum), and it's not removable with surgery
- You are in good enough health to have a small surgery (laparoscopy)
- Your blood counts and liver/kidney function are within a certain range
- You are willing to use birth control during the study and for 3 months after
- You have not had a blood transfusion or certain growth factor injections in the last 2 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving chemotherapy through a vein and directly into the belly before surgery for advanced stomach cancer. The goal is to shrink the cancer and see if this approach improves outcomes.
This study tests whether a thorough surgery to remove stomach cancer in the abdomen, followed by chemotherapy given through the belly and by vein, can improve outcomes. It’s for people newly diagnosed with stomach cancer that has limited spread to the belly lining.
This trial tests a new way to give chemotherapy directly into the abdomen during surgery for stomach cancer that has a high risk of coming back. It may help reduce the chance of the cancer returning.
This study tests a combination of two treatments for stomach cancer that has spread to the lining of the belly. It uses an immunotherapy drug (tislelizumab) plus standard chemotherapy (SOX) and a heated chemotherapy treatment directly into the belly (HIPEC) to see if this approach is safe and effective.
This trial tests adding the chemotherapy drug paclitaxel directly into the abdomen (intraperitoneal) along with standard IV chemotherapy for people with stomach or gastroesophageal junction cancer that has spread to the lining of the abdomen. The goal is to see if this combination helps control the cancer better than standard treatment alone.
This trial tests if surgery to remove visible cancer in the belly combined with heated chemotherapy placed directly into the abdomen can help people with stomach cancer that has spread to the lining of the belly. It is for patients who are well enough to undergo major surgery and meet specific health requirements.
Hear when a new Advanced Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.